55 related articles for article (PubMed ID: 17473820)
1. Benign prostatic hyperplasia and subsequent risk of bladder cancer.
Kang D; Chokkalingam AP; Gridley G; Nyren O; Johansson JE; Adami HO; Silverman D; Hsing AW
Br J Cancer; 2007 May; 96(9):1475-9. PubMed ID: 17473820
[TBL] [Abstract][Full Text] [Related]
2. 5-alpha reductase inhibitors (5-ARi) with or without alpha-blockers (α-B) for Benign Prostatic Hyperplasia do NOT lower the risk of incident Bladder Cancer: United States insurance claims data.
Del Giudice F; Belladelli F; Glover F; Basran S; Li S; Mulloy E; Pradere B; Soria F; Krajewski W; Nair R; Muncey W; Seranio N; Eisenberg ML
World J Urol; 2023 Oct; 41(10):2783-2791. PubMed ID: 37548746
[TBL] [Abstract][Full Text] [Related]
3. Nationwide incidence and treatment pattern of benign prostatic hyperplasia in Korea.
Lee YJ; Lee JW; Park J; Seo SI; Chung JI; Yoo TK; Son H
Investig Clin Urol; 2016 Nov; 57(6):424-430. PubMed ID: 27847916
[TBL] [Abstract][Full Text] [Related]
4. Sleep disruption and Alzheimer's disease risk: Inferences from men with benign prostatic hyperplasia.
Nørgaard M; Horváth-Puhó E; Corraini P; Sørensen HT; Henderson VW
EClinicalMedicine; 2021 Feb; 32():100740. PubMed ID: 33681742
[TBL] [Abstract][Full Text] [Related]
5. National-wide data on the treatment of BPH in Korea.
Kang JY; Min GE; Son H; Kim HT; Lee HL
Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):243-7. PubMed ID: 21502967
[TBL] [Abstract][Full Text] [Related]
6. New research in bladder cancer, ASCO-GU 2017.
Black PC; Sridhar S
Can Urol Assoc J; 2017 Jun; 11(6Suppl2):S160-S162. PubMed ID: 28616119
[No Abstract] [Full Text] [Related]
7. From TURP to enucleation: navigating the complex relationship between BPH treatments and bladder cancer.
Lin YH; Tsai HY; Wu CT
World J Urol; 2024 Mar; 42(1):203. PubMed ID: 38551707
[No Abstract] [Full Text] [Related]
8. Association of PSA variability with prostate cancer development using large-scale medical information data: a retrospective cohort study.
Maeda-Minami A; Nishikawa T; Ishikawa H; Mutoh M; Akimoto K; Matsuyama Y; Mano Y; Uemura H
Genes Environ; 2023 Oct; 45(1):25. PubMed ID: 37848957
[TBL] [Abstract][Full Text] [Related]
9. Systematic Evaluation of Imaging Features of Early Bladder Cancer Using Computed Tomography Performed before Pathologic Diagnosis.
Malik RF; Berry R; Lau BD; Busireddy KR; Patel P; Patel SH; Fishman EK; Bivalacqua TJ; Johnson PT; Sedaghat F
Tomography; 2023 Sep; 9(5):1734-1744. PubMed ID: 37736991
[TBL] [Abstract][Full Text] [Related]
10. Genetically supported causality between benign prostate hyperplasia and urinary bladder neoplasms: A mendelian randomization study.
Du W; Wang T; Zhang W; Xiao Y; Wang X
Front Genet; 2022; 13():1016696. PubMed ID: 36468030
[No Abstract] [Full Text] [Related]
11. Oncological safety and quality of life in men undergoing simultaneous transurethral resection of bladder tumor and prostate: results from a randomized controlled trial.
Dellabella M; Branchi A; Gasparri L; Claudini R; Castellani D
World J Urol; 2018 Oct; 36(10):1629-1634. PubMed ID: 29725805
[TBL] [Abstract][Full Text] [Related]
12. Identifying temporal patterns in patient disease trajectories using dynamic time warping: A population-based study.
Giannoula A; Gutierrez-Sacristán A; Bravo Á; Sanz F; Furlong LI
Sci Rep; 2018 Mar; 8(1):4216. PubMed ID: 29523868
[TBL] [Abstract][Full Text] [Related]
13. Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study.
Fang CW; Liao CH; Wu SC; Muo CH
World J Urol; 2018 Jun; 36(6):931-938. PubMed ID: 29427001
[TBL] [Abstract][Full Text] [Related]
14. Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies.
Dai X; Fang X; Ma Y; Xianyu J
Medicine (Baltimore); 2016 May; 95(18):e3493. PubMed ID: 27149447
[TBL] [Abstract][Full Text] [Related]
15. Chronic Indwelling Urinary Catheter Increase the Risk of Bladder Cancer, Even in Patients Without Spinal Cord Injury.
Ho CH; Sung KC; Lim SW; Liao CH; Liang FW; Wang JJ; Wu CC
Medicine (Baltimore); 2015 Oct; 94(43):e1736. PubMed ID: 26512566
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of simultaneous transurethral GreenLight photoselective vaporization of bladder tumor and prostate in patients with bladder tumor and lower urinary tract symptoms.
Li Z; Hou R; Li J
Int Urol Nephrol; 2014 Apr; 46(4):691-4. PubMed ID: 24097277
[TBL] [Abstract][Full Text] [Related]
17. Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan.
Tseng CH
BMC Cancer; 2013 Jan; 13():7. PubMed ID: 23286275
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
